Press Releases May 22, 2026 04:15 PM

Empro Group Inc. Announces Receipt of Delinquency Notification from Nasdaq

Empro Group Inc. Receives Nasdaq Notice for Non-Compliance Due to Delayed Form 20-F Filing

By Derek Hwang EMPG

Empro Group Inc., a Malaysia-based beauty and personal care company listed on Nasdaq, announced it received a notification from Nasdaq concerning non-compliance with listing rules due to the delayed filing of its annual Form 20-F for fiscal year 2025. The company has 60 days to submit a plan to regain compliance and potentially up to 180 additional days to file. Trading has been suspended since October 2025 and remains unaffected by this notice.

Empro Group Inc. Announces Receipt of Delinquency Notification from Nasdaq
EMPG

Key Points

  • Empro Group has not filed its annual Form 20-F for fiscal year ended December 31, 2025, leading to Nasdaq non-compliance notice.
  • The company has 60 days to submit a plan to Nasdaq and may receive up to 180 extra days to regain compliance if the plan is accepted.
  • Trading of Empro Group's shares on Nasdaq has been suspended since October 2025 and remains suspended.
  • Sectors impacted include the beauty and personal care sector, capital markets, and regulatory compliance in US stock exchanges.

Selangor, Malaysia, May 22, 2026 (GLOBE NEWSWIRE) -- Empro Group Inc. (Nasdaq: EMPG) (“Empro Group” or the “Company”), a rising beauty and personal care brand headquartered in Malaysia, today announced that on May 19, 2026 it received a notice from The Nasdaq Stock Market stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because the Company has not yet filed its annual report on Form 20-F for the fiscal year ended December 31, 2025.

Under Nasdaq rules, the Company has 60 calendar days to submit a plan to regain compliance and, if such plan is accepted by Nasdaq, an exception of up to 180 calendar days from the original filing’s due date may be granted, or until November 11, 2026, to regain compliance. If the plan to regain compliance is not accepted, the Company will have the opportunity to appeal that decision to a Hearings Panel.

The Company is currently working with its accounting, audit and legal professionals to prepare the Company’s Form 20-F for the fiscal year ended December 31, 2025, as well as to prepare and submit a compliance plan to Nasdaq. Trading of the Company’s ordinary shares on Nasdaq, which has been suspended since October 9, 2025, is not currently affected by this notice.

About Empro Group Inc.

Empro Group Inc. is a rising beauty and personal care brand headquartered in Malaysia. Evolving from its origins in Malaysia’s eyebrow embroidery space, Empro Group has grown into a trusted name across three core pillars: cosmetics, skincare, and healthcare. With a growing presence across Southeast Asia and Europe, Empro Group Inc. remains dedicated to offering accessible, quality self-care solutions while staying true to its humble beginnings. For more information please visit: https://www.empro.my/.

Forward-Looking Statement

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These forward-looking statements are subject to uncertainties and risks, including, without limitation, those risk factors that are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

Investor Relations
Visit emproinc.co
Or contact us at [email protected]


Risks

  • Failure to file the Form 20-F or have the compliance plan accepted by Nasdaq could lead to delisting, harming shareholders and the company’s market access.
  • Trading suspension limits liquidity and investor confidence, potentially impacting company valuation and capital raising ability.
  • Delays in regulatory compliance filings reflect operational or financial challenges that may affect company reputation and business prospects.

More from Press Releases

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions Jun 4, 2026 Xos Makes Its GFX Debut with Electric Vehicles, Powertrain Technology, and Mobile Charging for Public Fleets Jun 4, 2026 Satellogic to Participate in June Investor Conferences Jun 4, 2026 BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. Jun 4, 2026 SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026 Jun 4, 2026